AVE 25.0% 0.3¢ avecho biotechnology limited

'did not reach theraputic levels severe pain', page-8

  1. 4,172 Posts.
    lightbulb Created with Sketch. 68
    These results are encouraging & the coy should seek to publish their findings in a major medical journal for the scrutiny of their peers and clarity for investors ( old & new ) not to mention the international promotion of their science . If there is a failure to publish many will keep the red flag flying ! Esra let the world know what we'r doing ,selecting target partners in the past with ur developements can only be judged by the present SP .
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.